MFAP5 inhibits the malignant progression of endometrial cancer cells in vitro
2024
MFAP5 and Endometrial Cancer
publication
Evidence: moderate
Author Information
Author(s): Liang Guanying, Qi Zijuan, Du Chun
Primary Institution: Department of Pathology, Harbin Medical University Cancer Hospital
Hypothesis
What is the biological role of MFAP5 in endometrial cancer?
Conclusion
MFAP5 overexpression inhibits the malignant behaviors of endometrial cancer cells, possibly by blocking the AKT/mTOR pathway.
Supporting Evidence
- MFAP5 was found to be down-regulated in endometrial cancer tissues.
- Overexpression of MFAP5 suppressed proliferation and promoted apoptosis in cancer cells.
- MFAP5 overexpression reduced cell migration and invasion capabilities.
- MFAP5 overexpression increased E-cadherin and decreased N-cadherin and α-SMA levels.
Takeaway
MFAP5 is a protein that helps control how cancer cells grow and spread. When we increase its levels in endometrial cancer cells, they grow less and die more.
Methodology
The study involved creating cell lines that overexpress MFAP5 and evaluating their proliferation, apoptosis, migration, and invasion using various assays.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website